FDA Drug Application (020250) for HALFAN by GLAXOSMITHKLINE

Back to FDA Applications sponsored by GLAXOSMITHKLINE

Application Number020250
Product Number001
FormTABLET;ORAL
Dosage250MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameHALFAN
Active IngredientHALOFANTRINE HYDROCHLORIDE



Back to FDA Applications sponsored by GLAXOSMITHKLINE